Nov 17, 2020 7:00 am EST Cerecor to Collaborate with Frontiers CDG Consortium on Pivotal Trial of CERC-801 for the Treatment of PGM1-CDG
Nov 9, 2020 4:01 pm EST Cerecor Reports Third Quarter 2020 Financial Results and Provides Business Update
Aug 26, 2020 7:00 am EDT Cerecor Resumes Phase 1b Clinical Trial of CERC-002 for the Treatment of Severe Pediatric Onset Crohn’s Disease
Aug 13, 2020 7:00 am EDT Cerecor Announces Peer-Reviewed Publication Highlighting the Role of the Inflammatory Cytokine, LIGHT, in COVID-19 ARDS
Aug 4, 2020 7:00 am EDT Cerecor Receives Rare Pediatric Disease Designation for CERC-006 in Lymphatic Malformations
Aug 3, 2020 7:00 am EDT Cerecor Receives Orphan Drug Designation for CERC-006 in Lymphatic Malformations
